Learning Objectives:

Describe disparities in treatment of atrial fibrillation.

Identify the drivers of pharmacoequity.

Session date: 
02/15/2022 - 12:00pm to 1:00pm CST
Location: 
Virtual/P-117
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Utibe R. Essien, MD, MPH